PhysicsWallah IPO: Should You Invest? An In-Depth Analysis
Get the latest updates on the PhysicsWallah IPO, including the price band, issue details, and analysis from Anand Rathi’s report to help you make an informed investment decision.
Blog
Blog
Your blog category
Blog
PhysicsWallah IPO Day 1 Live Updates: Key Details, GMP, Analyst Views, and Subscription Status
Get the latest updates on the PhysicsWallah IPO, including key details, GMP, analyst views, and subscription status. Find out how to invest in the PhysicsWallah IPO and what to expect from the listing.
Blog
Stock Market LIVE: Nifty, Sensex Recover As Airtel, HDFC Bank Shares Gain
The NSE Nifty 50 and BSE Sensex erased losses as Bharti Airtel Ltd. and HDFC Bank Ltd. shares supported, while InterGlobe Aviation Ltd. and Bharat Electronics Ltd. were top gainers in the NSE Nifty 50 index.
Blog
Bharat Forge Q2 Results: Profit Rises 23%; Shares Jump Nearly 4%
Bharat Forge Ltd.’s profit rises 23% to Rs 299.20 crore in the second quarter of this financial year, with revenue advancing by 9.3% year-on-year.
Blog
Emmvee Photovoltaic IPO: Should You Invest? Expert Analysis and Key Details
Get the latest updates on the Emmvee Photovoltaic IPO, including key issue details, price band, and expert analysis to help you make an informed investment decision.
Blog
Q2 Earnings Season: Bharat Forge, Cera, Bajaj Finserv, and Biocon Under Spotlight
The Q2 earnings season is in full swing, with several key companies declaring their results. Bharat Forge, Cera, Bajaj Finserv, and Biocon are among the top stocks in focus. Get the latest updates and analysis on their Q2 performance.
Blog
Pine Labs IPO: Should You Invest? Expert Analysis and Key Details
Pine Labs Ltd. has launched its initial public offering, aiming to raise Rs 3,899.91 crore. Here’s what you need to know before investing.
Blog
Hindalco Q2 Results: What Do The Numbers Mean For Indian Investors?
Hindalco Industries Ltd has reported a 21.2% rise in consolidated profit after tax at Rs 4,741 crore in the quarter ended September 2025. What does this mean for Indian investors and the broader metals industry?
Blog
Indoco Remedies Q2 Review: Dolat Capital Revises Target Price Amidst ‘Sell’ Rating
Indoco Remedies’ Q2 FY26 earnings exceeded estimates, but Dolat Capital maintains a ‘Sell’ rating with a revised target price. Understand the implications for investors.
Blog
Nykaa Q2 Results: A Comprehensive Analysis of the E-Commerce Giant’s Performance
Nykaa’s Q2 results have sent shockwaves in the Indian stock market, with the company’s net profit tripling and revenue rising by 25.1%. Here’s a detailed analysis of the e-commerce giant’s performance.